Open-Label, Long-Term Extension Study for Treatment of Breakthrough Cancer Pain With BEMA Fentanyl.
Phase of Trial: Phase III
Latest Information Update: 21 Dec 2018
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions
- Sponsors BioDelivery Sciences International
- 31 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 31 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.